If you can’t make money from cannabis, there’s always psychedelics.
Little Green Pharma’s foray into psychedelic Reset Mind Sciences, a subsidiary of cannabis stock Little Green Pharma (ASX:LGP), will partner with HIF to establish a proof-of-concept mental health treatment facility that could deliver psychedelic assisted psychotherapy to patients. Under the ‘strategic alliance’, both parties will also undertake a health economics study to provide HIF (Health Insurance Fund of Australia) with the real-world data necessary to inform potential member coverage for this treatment.
Little Green Pharma’s foray into psychedelic Reset Mind Sciences, a subsidiary of cannabis stock Little Green Pharma (ASX:LGP), will partner with HIF to establish a proof-of-concept mental health treatment facility that could deliver psychedelic assisted psychotherapy to patients. Under the ‘strategic alliance’, both parties will also undertake a health economics study to provide HIF (Health Insurance Fund of Australia) with the real-world data necessary to inform potential member coverage for this treatment.
Source: Stockhead